Celsion Corporation (CLSN)

[ThousandDollarSuit]

The new GEN-1 technology is groundbreaking.

Video:

Celsion Corporation ($CLSN) has received Fast Track designation from the U.S. FDA for "GEN-1" its DNA-mediated treatment of advanced ovarian cancer. The fundamental science is GROUNDBREAKING! They design a specific DNA-based immunotherapy to specifically target the DNA of each individual patient's cancer, which spares the surrounding healthy tissue. The humanitarian value is priceless and the business value has potentially unlimited upside, as this approach gets extended to cancers other than ovarian cancer, over time. As a scientist, I foresee many licenses for this technology to be used by other companies curing other cancers in the future.